Skip to main content
Clinical Trials/NCT05194696
NCT05194696RecruitingNot Applicable

The Impact of Caffeine Consumption on Preventing Cataract

Vienna Institute for Research in Ocular Surgery1 site in 1 country12,000 target enrollmentStarted: September 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
12,000
Locations
1
Primary Endpoint
Caffeine consumption

Study Overview

Brief Summary

Effect of peroral caffeine consumption on the delay of cataract onset.

Detailed Description

Several experimental studies have shown that caffeine inhibits cataract development by scavenging reactive oxygen species. Evidence from epidemiological studies, however, is controversial. Varma et al., found that the incidence of cataract blindness in humans was significantly lower in groups consuming higher amounts of coffee in comparison to the groups with lower coffee intake. Moreover, Rautiainen et al. showed that the dietary total antioxidant capacity including coffee of middle-aged and elderly women was inversely associated with the risk of age-dependent cataract. Another population-based study involving the population residing in Beaver Dam, Wisconsin, did not find a meaningful association between 10-year cumulative incidence of cataract and the amount of caffeine intake.

Although cataracts can be surgically removed, barriers that prevent access to surgery are a problem in many countries. Moreover, no prophylactic treatments are currently available to prevent the onset of cataract. Yet estimates indicate that a delay of only 10 years in the onset of cataract could reduce the need for cataract surgery by as much as 50%.

The present study aims to investigate whether peroral caffeine consumption on a regular daily basis for a significant period of time and sufficient dose delays cataract development.

12000 eyes of 6000 patients will be included into this study. Patient will have to fill out a questionnaire for caffeine consumption habits during lifetime and risk factors for cataract development. Further, a complete ophthalmic examination, cataract grading, refraction, visual testing, and biometry will be performed.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
21 Years to 105 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age older than 21 years

Exclusion Criteria

  • age younger than 21 years

Outcomes

Primary Outcomes

Caffeine consumption

Time Frame: 48 months

Caffeine consumption will be assessed using a questionnaire concerning the caffeine drinking habits

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Vienna Institute for Research in Ocular Surgery
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prim. Prof. Dr. Oliver Findl, MBA

Principal Investigator

Vienna Institute for Research in Ocular Surgery

Study Sites (1)

Loading locations...

Similar Trials

Caffeine Consumption and Cataract... | Clinical Trial